The Creyos Dementia Assessment and Care Plan is a cognitive care protocol that pairs a quick cognitive screen with a full assessment battery and an embedded care planning tool. It paves the way for earlier detection of mild cognitive impairment (MCI) and dementia, helping clinicians expand their assessment capabilities, intervene earlier, and better manage patients’ care needs.
Article Highlights
The Creyos Dementia Assessment and Care Plan combines a cognitive screener, a full assessment battery, and a care planning tool in one protocol.
- The two-task cognitive screener takes less than 5 minutes and determines whether further testing is needed.
- An Alzheimer’s Association survey found only 47% of primary care physicians regularly test patients 65 and older for cognitive impairment.
- Results are benchmarked by age group against a normative database of over 85,000 participants, and assessments can be repeated to track cognitive change over time.
Over 7 million Americans are living with Alzheimer’s disease, and that number is expected to grow to 13 million by 2050 in line with an aging population. Still, a significant gap remains in the detection of mild cognitive impairment and dementia.
An Alzheimer’s Association survey found that only 47% of primary care physicians regularly test patients 65 years and older for cognitive impairment. And 96% of physicians would welcome more information about cognitive assessments, including what cognitive assessment tools to use in their practice, suggesting they may be unaware of what is available.
Clinicians may cite limited time to see patients, administrative burden, or a lack of specialized training as barriers to regularly assessing patients’ cognition. All of these factors can then contribute to the underdiagnosis of mild cognitive impairment and dementia.
To properly address this growing need for assessment while reducing the administrative burden, clinicians are turning to technology, investing in computerized cognitive screening tools aligned with the Alzheimer’s Association’s recommendations to help them more effectively screen patients for cognitive decline.
Effective computerized cognitive testing tools need to balance scientific validity and efficiency. They should be easy for patients to complete, and they need to give clinicians the precise and detailed insights needed to make informed decisions regarding patients’ cognitive healthcare.
What’s included in the Creyos Dementia Assessment and Care Plan?
The Creyos Dementia Assessment and Care Plan gives clinicians a comprehensive solution for providing high-quality cognitive care.
This comprehensive protocol gives clinicians:
- A quick cognitive screener to identify impairment and determine if further testing is needed.
- A full assessment battery to help establish diagnostic criteria for mild or major neurocognitive disorders, allowing clinicians to make more confident and precise diagnoses.
- A prepackaged cognitive care planning tool that gives clinicians next steps and care teams structured plans to better manage their patients’ safety and quality of life.
Together, these resources enable clinicians to effectively detect, monitor, and manage cognitive impairment.
Cognitive screener for initial detection
Creyos’s scientifically validated two-task cognitive screener takes less than 5 minutes to complete and identifies signs of cognitive impairment (commonly an early sign of dementia) quickly to determine whether further testing is needed.
Full assessment battery for cognitive and functional evaluation
If impairment is detected, patients progress to complete further assessment in Creyos. The full assessment protocol includes additional tasks that measure more areas of cognition and rating scales to assess subjective impairment, functional dependence, and neuropsychiatric symptoms.
The testing approach aligns with the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) criteria and automatically tabulates test results, reducing the time it takes to gather patient information and helping to confirm and document criteria for MCI and dementia.
Comprehensive care planning
For patients with identified cognitive impairment, clinicians can use Creyos to quickly generate detailed, personalized, Medicare-aligned care plans, including lifestyle advice, medication management, and caregiver guidance. These actionable plans give patients and care teams clear next steps while helping reduce caregiver strain.
Tracking and longitudinal testing
Creyos assessments are built to reassess patients, so you can track changes in a patient’s cognitive health over time. The scientifically validated tests present randomized problem sets every time to reliably relate patient performance to previous results and normative data. This makes it easy to see at a glance whether cognition is stable or declining and helps guide meaningful conversations with patients and their caregivers about how the condition is progressing.
How to administer the Creyos Dementia Assessment
1. Start a protocol from the Patient Details page
Within the Creyos platform, navigate to the Patient Details page. Once there, start a protocol.
2. Choose an administration method
As with all Creyos assessments, the test can be administered remotely or in person. Choose how you would like to administer the assessment and send a link or an email to your patient to complete the assessment either in the clinic or at home.
3. Choose a custom or condition-focused protocol
A new screen will appear with the option to choose between two types of protocols.
- Selecting "Administer Your Own Protocol" will take you down the familiar path of either choosing an existing protocol you have created or creating a custom protocol on the fly.
- Selecting "Choose A Condition-Focused Protocol" will allow you to administer the pre-built dementia protocol.
4. Select the MCI Assessment protocol
On the next page, select “MCI Assessment” from the available condition-focused protocols.
If you’d like to administer a custom assessment instead, you can also navigate back to a custom protocol flow by clicking "Would you rather administer your own protocol?" You can then assemble your own set of tasks and questionnaires.
What is the science behind the Creyos cognitive screen?
The science behind Creyos comes from over 30 years of research and a normative database consisting of over 85,000 participants.
Addressing the need for physicians to have a fast yet comprehensive way to detect age-related impairment, Creyos created a screening algorithm based on scores from two online cognitive tasks from its established library, resulting in efficient, sensitive, and specific detection of potential age-related cognitive impairment.
Early detection of cognitive impairment and dementia is critical for improving patients’ quality of life. Yet capture rates for these conditions can be low, and traditional tools like the Mini-Cog, Montreal Cognitive Assessment (MoCA), and Saint Louis University Mental Status (SLUMS) examination may have limitations for detecting early stages of the condition.
For more information on the science behind the Creyos Dementia Assessment, read the Dementia Protocol Science Overview.
Benefits of Creyos dementia screening in primary care and neurology
The Creyos approach to dementia screening, assessment, and care planning is designed to help physicians close the gap in dementia detection and cognitive care planning.
Creyos dementia screening in primary care
Primary care clinicians are expected to deliver complete patient care, including monitoring and maintaining brain health. In fact, under Medicare, an annual wellness visit requires a cognitive assessment. However, many physicians are limited by time, lack of specialized training, or administrative burden.
The benefits of Creyos for primary care clinicians include:
- Enhanced value of service. With no specialized training required, primary care clinicians can expand their capabilities and regularly test patients’ cognition.
- Improved capture rates. Respond effectively to patients’ memory concerns using assessments that are sensitive to detecting impairment with rigorous scientific backing.
- Early dementia detection. Earlier detection means clinicians can initiate appropriate interventions sooner for better patient care and informed treatment.
- Better operational efficiency. Cognitive screens and testing protocols can be administered during a pre-visit or annual wellness visit. These can be administered in person, or a patient can complete them at home without physician oversight. Seamless communications, automated reporting, and electronic health record (EHR) integration are built right into the Creyos platform for optimized workflows.
Creyos dementia screening for neurologists
As specialists in brain health, neurologists often see patients with known cognitive impairment when their condition has progressed to a point that it impacts daily life. Other screening tools may only scratch the surface when it comes to symptom detection and don’t provide the detailed, objective data that is valuable for developing effective care plans.
The benefits of Creyos for neurologists include:
- Cognitive domain-specific reports. In-depth reports highlight specific cognitive functions that are impaired in an easy-to-interpret manner.
- Assessment of comorbid conditions. Behavioral questionnaires are included to offer insights into a wide range of symptoms beyond cognitive impairment (e.g., depression), providing a more complete sense of the patient’s well-being.
- Automated scoring. The patient’s cognitive performance is benchmarked in the context of their age group against the Creyos normative database of over 85,000 participants.
- Patient retention. With Creyos, neurologists can often manage all parts of cognitive assessment and care planning. They may also be able to address behavioral symptoms in one platform, making it easier to keep patients in their care.
Closing the gap in cognitive care
The Creyos Dementia Assessment and Care Plan was developed with clinicians’ needs in mind. With over 7 million Americans living with Alzheimer’s disease, a number expected to reach 13 million by 2050, this protocol equips physicians with the tools needed to successfully detect and manage cognitive decline.
The end-to-end screening, assessment, and care planning capabilities come standard as part of every Creyos online subscription.
Reviewed by Mike Battista, Director of Science & Research at Creyos
Mike Battista specializes in brain health, cognition, and neuropsychological testing. He received his PhD in personality and measurement psychology at Western University in 2010 and has been doing fun and useful stuff in the intersection between science and technology ever since.